Antibodies for Cancer Research
Cancer Research Antibodies
At Atlas Antibodies we have a strong focus on cancer and offer a wide selection of PrecisA Monoclonals™ and Triple A Polyclonals™ for cancer research.
Triple A Polyclonals for cancer research
Triple A Polyclonals are rabbit polyclonal antibodies developed within the Human Protein Atlas project. We offer 21,000 Triple A Polyclonals, each supplied with more than 500 annotated IHC images including images from cancerous tissues. The antibodies have been used for staining of 48 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type.
Cancer Stem Cell Markers
Cancer stem cells (CSCs) are a small number of cells that drive the tumor’s initiation, growth and metastasis, and may cause relapse. Due to their importance, several biomarkers that characterize CSCs have been identified, allowing diagnostic, therapeutic, and prognostic predictions. Atlas Antibodies offer antibodies targeting several proteins relevant as CSC markers, focusing on solid and hematological cancers.
Mechanisms in Cancer
Cell Cycle Markers
Cell Death Markers
Metastasis Markers
Tumor Angiogenesis and Lymphoangiogenesis Markers
Tumor Proliferation Markers
ATRX and Glioma Markers
Glioma is a common type of brain tumor, that springs from glial cells. The tumor type comprises about 80% of all malignant brain tumors and often carry a very poor prognosis. Atlas Antibodies offer antibodies targeting several proteins relevant for glioma characterization, including ATRX, IDH1, and GFAP.
Oncology Biomarkers
Atlas Antibodies recognize the need for new biomarkers to provide a more accurate diagnosis and a better assessment of patient prognosis, ultimately leading to a more individualized treatment. Together with our research partners in the Human Protein Atlas project we are in a unique position to perform antibody-based biomarker discovery. Learn about our oncology biomarkers T-PIT / TBX19, SATB2, PODXL and RBM3.
EMT Markers
The Epithelial-to-Mesenchymal Transition (EMT) is a process that normally occurs during embryogenesis, but is also present in wound healing and cancer progression of epithelial tumors. Our EMT marker antibody panel includes mouse monoclonals targeting key EMT markers for cell junctions, cytoskeletal changes, transcription regulation and migration/motility.
Colorectal Cancer
A large number of our antibodies are relevant for scientists studying colorectal cancer. In this brochure, we catalog our antibodies related to the field of colorectal cancer research together with publication references.
Breast Cancer
A wide range of our antibodies is used by scientists working to understand breast cancer. In this brochure, we catalog our antibodies related to the field of breast cancer research together with publication references.
Pathology Atlas
The Pathology Atlas section of the Human Protein Atlas provides information on the role of genes, RNA, proteins, and metabolites in the human cancerous tissues and organs. It is a valuable resource helping researchers and pathologists to improve testing methods to predict and find new treatments for fighting cancer.